Status:
COMPLETED
Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Stem Cell Transplantation
Haplo-identical
Eligibility:
All Genders
18+ years
Brief Summary
The occurrence of acute and/or chronic GVH (Graf Versus Host disease) for recipients undergoing HSCT (haematopoietic stem cell transplantation) with a geno-identical donor suggests the implication of ...
Eligibility Criteria
Inclusion
- \- Recipients who underwent haplo-identical stem cell transplantation in CHRU (Centre Hospitalier Régional et Universitaire) de Nancy
- Recipients transplanted between 03/01/2015 et 01/01/2020
- Recipient older than 18 years old at time of transplant
- Available DNA for the recipient and his donor.
Exclusion
- Recipient died within the 6 months following the transplantation without acute GVH (unknown status for one of the measured outcomes)
Key Trial Info
Start Date :
March 23 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 6 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05243498
Start Date
March 23 2015
End Date
November 6 2020
Last Update
February 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alice Aarnink
Vandœuvre-lès-Nancy, France, 54500